The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Central monoamines and their role in major depression
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inositol trisphosphate and calcium signalling
Berridge, M. J. (1993) · Nature · doi:10.1038/361315a0 · Cited by 6,545
Dahlstroem, A., & Fuxé, K. (1964) · PubMed · Cited by 5,133
Higgins, S. M. F., Macken, A. P., Cullen, W., Saunders, J., Dunne, C. P., & O’Gorman, C. S. (2013) · PubMed · doi:10.34961/9953 · Cited by 4,806
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
SCHILDKRAUT, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,492
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Nucleus locus ceruleus: new evidence of anatomical and physiological specificity
Foote, S. L., Bloom, F. E., & Aston-Jones, G. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.3.844 · Cited by 1,901
Ferguson, S. S. G. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01478-9 · Cited by 1,826
Psychopharmacology: The Fourth Generation of Progress
Brophy, J. J. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530220079046 · Cited by 1,582
Presynaptic regulation of the release of catecholamines.
Langer, S. Z. (1980) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06843-7 · Cited by 1,490
Heterotrimeric C proteins: Organizers of transmembrane signals
Neer, E. J. (1995) · Cell · doi:10.1016/0092-8674(95)90407-7 · Cited by 1,405
The role of corticotropin-releasing factor in depression and anxiety disorders
Arborelius, L., Owens, M., Plotsky, P., & Nemeroff, C. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600001 · Cited by 1,378
International Union of Pharmacology nomenclature of adrenoceptors.
Bylund, D. B., Eikenberg, D. C., Hieble, J. P., Langer, S. Z., Lefkowitz, R. J., Minneman, K. P., Molinoff, P. B., Ruffolo, R. R., & Trendelenburg, U. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06780-8 · Cited by 1,218
Moore, R. Y., & Bloom, F. E. (1979) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.02.030179.000553 · Cited by 1,118
Differences between males and females in rates of serotonin synthesis in human brain
Nishizawa, S., Benkelfat, C., Young, S. N., Leyton, M., Mzengeza, S., de Montigny, C., Blier, P., & Diksic, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5308 · Cited by 900
Dopamine receptors and the dopamine hypothesis of schizophrenia
Seeman, P. (1987) · Synapse · doi:10.1002/syn.890010203 · Cited by 880
Recent Advances in the Molecular Biology of Dopamine Receptors
Gingrich, J. A., & Caron, M. G. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.001503 · Cited by 779
The Uptake and Storage of Noradrenaline in Sympathetic Nerves
(1967) · Postgraduate Medical Journal · doi:10.1136/pgmj.43.505.726-a · Cited by 745
Mammalian Membrane-bound Adenylyl Cyclases
Taussig, R., & Gilman, A. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.1.1 · Cited by 721
Lapin, I. P., & Oxenkrug, G. F. (1969) · The Lancet · doi:10.1016/s0140-6736(69)91140-4 · Cited by 709
Artigas, F., Romero, L., de Montigny, C., & Blier, P. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10037-0 · Cited by 655
THE TREATMENT OF DEPRESSIVE STATES WITH G 22355 (IMIPRAMINE HYDROCHLORIDE)
KUHN, R. (1958) · American Journal of Psychiatry · doi:10.1176/ajp.115.5.459 · Cited by 615
The uptake and storage of Noradrenaline in Sympathetic Nerves
Norberg, K.-A. (1967) · Brain Research · doi:10.1016/0006-8993(67)90033-9 · Cited by 598
Catecholamine metabolism: basic aspects and clinical significance.
Kopin, I. J. (1985) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06859-0 · Cited by 582
Autoregulation of Serotonin Neurons: Role in Antidepressant Drug Action
Piñeyro, G., & Blier, P. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01417-0 · Cited by 537
Is there a role for 5-HT1A agonists in the treatment of depression?
Blier, P., & Ward, N. M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01643-8 · Cited by 529
Celada, P., Puig, M. V., Casanovas, J. M., Guillazo, G., & Artigas, F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09917.2001 · Cited by 497
Sonders, M. S., Zhu, S.-J., Zahniser, N. R., Kavanaugh, M. P., & Amara, S. G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-03-00960.1997 · Cited by 444
Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists
Baraban, J. M., & Aghajanian, G. K. (1980) · Neuropharmacology · doi:10.1016/0028-3908(80)90187-2 · Cited by 440
Neurotransmitter Transporters in the Central Nervous System
Masson, J., Sagné, C., Hamon, M., & El Mestikawy, S. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01414-5 · Cited by 416
BLIER, P., de MONTIGNY, C., & CHAPUT, Y. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198712001-00003 · Cited by 404
The D3 Dopamine Receptor: Neurobiology and Potential Clinical Relevance
Levant, B. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01327-9 · Cited by 385
Effect of Psychotropic Drugs on the Uptake of H 3 -Norepinephrine by Tissues
Axelrod, J., Whitby, L. G., & Hertting, G. (1961) · Science · doi:10.1126/science.133.3450.383 · Cited by 364
The Family of Na+/Cl− Neurotransmitter Transporters
Nelson, N. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71051785.x · Cited by 358
Hrdina, P. D., Demeter, E., Vu, T. B., Sótónyi, P., & Palkovits, M. (1993) · Brain Research · doi:10.1016/0006-8993(93)91015-k · Cited by 327
Vizi, E. S. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01436-4 · Cited by 313
(1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.6.730 · Cited by 313
Mechanisms of signal transduction at the dopamine D2 receptor
Vallar, L., & Meldolesi, J. (1989) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(89)90082-5 · Cited by 312
Delgado, P. L., Miller, H. L., Salomon, R. M., Licinio, J., Krystal, J. H., Moreno, F. A., Heninger, G. R., & Charney, D. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00014-1 · Cited by 307
Receptors for 5-Hydroxytryptamine: Current perspectives on classification and nomenclature
Martin, G. R., & Humphrey, P. P. A. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90058-2 · Cited by 305
Pérez, V., Gilaberte, I., Faries, D., Alvarez, E., & Artigas, F. (1997) · The Lancet · doi:10.1016/s0140-6736(96)08007-5 · Cited by 300
Higher Expression of Serotonin 5-HT2A Receptors in the Postmortem Brains of Teenage Suicide Victims
Pandey, G. N., Dwivedi, Y., Rizavi, H. S., Ren, X., Pandey, S. C., Pesold, C., Roberts, R. C., Conley, R. R., & Tamminga, C. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.3.419 · Cited by 281
Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins
FIELDS, T. A., & CASEY, P. J. (1997) · Biochemical Journal · doi:10.1042/bj3210561 · Cited by 280
Parachlorophenylalanine Reversal of Tranylcypromine Effects in Depressed Patients
Shopsin, B. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770070041003 · Cited by 265
Dopamine receptors in brain and periphery
Seeman, P., & Grigoriadis, D. (1987) · Neurochemistry International · doi:10.1016/0197-0186(87)90167-7 · Cited by 249
The pharmacology of putative early-onset antidepressant strategies
Blier, P. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00173-6 · Cited by 244
The Effect of Paroxetine on 5-HT2A Receptors in Depression: An [18F]Setoperone PET Imaging Study
Meyer, J. H., Kapur, S., Eisfeld, B., Brown, G. M., Houle, S., DaSilva, J., Wilson, A. A., Rafi-Tari, S., Mayberg, H. S., & Kennedy, S. H. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.1.78 · Cited by 231
Aghajanian, G. K., & Lakoski, J. M. (1984) · Brain Research · doi:10.1016/0006-8993(84)91137-5 · Cited by 231
Adell, A., & Artigas, F. (1991) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00251121 · Cited by 222
5-HT and antidepressants: new views from microdialysis studies
Artigas, F. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90125-4 · Cited by 215
Peroutka, S. J., & Snyder, S. H. (1980) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32343-8 · Cited by 211
Bioenergetics of secretory vesicles
Njus, D., Kelley, P. M., & Harnadek, G. J. (1986) · Biochimica et Biophysica Acta (BBA) - Reviews on Bioenergetics · doi:10.1016/0304-4173(87)90003-6 · Cited by 209
The mesolimbic dopamine system as a target for rapid antidepressant action
Willner, P. (1997) · International Clinical Psychopharmacology · doi:10.1097/00004850-199707003-00002 · Cited by 208
Fine Tuning of Sympathetic Transmitter Release via Ionotropic and Metabotropic Presynaptic Receptors
Boehm, S., & Kubista, H. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.1.43 · Cited by 206
Dennis, T., L'Heureux, R., Carter, C., & Scatton, B. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-5347(25)00278-2 · Cited by 199
Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration
Hensler, J. G. (2003) · Life Sciences · doi:10.1016/s0024-3205(02)02482-7 · Cited by 198
The effect of imipramine of central 5-hydroxytryptamine neurons
Carlsson, A., Fuxe, K., & Ungerstedt, U. (1968) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1968.tb09706.x · Cited by 194
Miller, H. L. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830020031005 · Cited by 192
The role of noradrenaline and selective noradrenaline reuptake inhibition in depression
Brunello, N. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00057-3 · Cited by 184
Predictors of Mood Response to Acute Tryptophan Depletion A Reanalysis
Booij, L. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00361-5 · Cited by 182
Gautam, N., Downes, G. B., Yan, K., & Kisselev, O. (1998) · Cellular Signalling · doi:10.1016/s0898-6568(98)00006-0 · Cited by 177
Hensler, J. G., Kovachich, G. B., & Frazer, A. (1991) · PubMed · Cited by 168
Hensler, J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00395-5 · Cited by 167
How Long Should Pindolol Be Associated With Paroxetine to Improve the Antidepressant Response?
Zanardi, R., Artigas, F., Franchini, L., Sforzini, L., Gasperini, M., Smeraldi, E., & Pérez, J. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199712000-00002 · Cited by 157
Shopsin, B., Gershon, S., Goldstein, M. N., Friedman, E., & Wilk, S. (1975) · PubMed · Cited by 157
Garcı́a-Sevilla, J. A., Escribá, P. V., Ozaita, A., Harpe, R. L., Walzer, C., Eytan, A., & Guimón, J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720282.x · Cited by 154
Current status of antidepressants: clinical pharmacology and therapy.
Baldessarini, R. J. (1989) · PubMed · Cited by 152
Molecular basis of human MAO A and B.
Shih, J. (1991) · PubMed · Cited by 146
Hrdina, P. D., & Vu, T. B. (1993) · Synapse · doi:10.1002/syn.890140410 · Cited by 144
Maes, M. H. J., Libbrecht, I., Hunsel, F. V., Campens, D., & Meltzer, H. Y. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199904000-00014 · Cited by 133
Charney, D. S., Heninger, G. R., Sternberg, D. E., Redmond, D. E., Leckman, J. F., Maas, J. W., & Roth, R. H. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780370036004 · Cited by 129
Haddjeri, N., Blier, P., & de Montigny, C. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12944-3 · Cited by 126
Tryptophan, mood, and cognitive function
Riedel, W. J., Klaassen, T., & Schmitt, J. A. J. (2002) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(02)00013-2 · Cited by 126
Szabo, S. T., & Blier, P. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01583.x · Cited by 125
Invernizzi, R. W., Bramante, M., & SAMANIN, R. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90344-1 · Cited by 124
Mottola, D. M., Kilts, J. D., Lewis, M. M., Connery, H. S., Walker, Q. D., Jones, S. R., Booth, R. G., Hyslop, D. K., Piercey, M., Wightman, R. M., et al. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1166 · Cited by 123
Castro, E., Díaz, Á., del Olmo, E., & Pazos, Á. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(02)00340-4 · Cited by 118
Scuvée‐Moreau, J., & Dresse, A. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90368-6 · Cited by 116
Hervás, I. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00175-5 · Cited by 115
Listening to Neurotransmitter Transporters
Lester, H. A., Cao, Y., & Mager, S. (1996) · Neuron · doi:10.1016/s0896-6273(00)80213-5 · Cited by 114
Tryptophan depletion and depressive vulnerability
Moreno, F., Gelenberg, A. J., Heninger, G. R., Potter, R. L., McKnight, K., Allen, J. J. B., Phillips, A. P., & Delgado, P. L. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00095-5 · Cited by 111
Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.
Smith, W. T., Glaudin, V., Panagides, J., & Gilvary, E. (1990) · PubMed · Cited by 110
Pindolol: A New β-Adrenoceptor Antagonist with Partial Agonist Activity
Koch‐Weser, J., & Frishman, W. H. (1983) · New England Journal of Medicine · doi:10.1056/nejm198304213081606 · Cited by 107
Klimek, V., Zak-Knapik, J., & Maćkowiak, M. (1994) · PubMed · Cited by 104
Depressions following reserpine: a reevaluation.
Goodwin, F. K., & Bunney, W. E. (1971) · PubMed · Cited by 97
Harkin, A., Kelly, J. P., McNamara, M. G., Connor, T. J., Dredge, K. S., Redmond, A., & Leonard, B. E. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00838-3 · Cited by 95
Malagié, I., Trillat, A., Bourin, M., Jacquot, C., Hen, R., & Gardier, A. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00083.x · Cited by 87
Crespi, F., Garratt, J. C., Sleight, A. J., et al. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90128-q · Cited by 85
Charney, D. S., Heninger, G. R., & Sternberg, D. E. (1983) · The British Journal of Psychiatry · doi:10.1192/bjp.142.3.265 · Cited by 84
Serotonergic Stimulation of Corticotropin‐Releasing Hormone and Pro‐Opiomelanocortin Gene Expression
Jørgensen, H., Knigge, U., Kjær, A., Møller, M., & Warberg, J. (2002) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2002.00839.x · Cited by 82
The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain
Maj, J., Bijak, M., Dziedzicka‐Wasylewska, M., Rogoż, R., Rogóż, Z., Skuza, G., & Tokarski, T. (1996) · Psychopharmacology · doi:10.1007/bf02805977 · Cited by 81
Antidepressant drugs given repeatedly increase binding to α1-adrenoceptors in the rat cortex
Maj, J., Klimek, V., & Nowak, G. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90328-0 · Cited by 81
Shen, C., Li, H., & Meller, E. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00064-3 · Cited by 80
Zanardi, R., Artigas, F., Moresco, R., Colombo, C., Messa, C., Gobbo, C. L., Smeraldi, E., & Fazio, F. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200102000-00010 · Cited by 80
Goodnough, D. B., & Baker, G. B. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62062262.x · Cited by 76
Millan, M. J., Newman‐Tancredi, A., Brocco, M., Gobert, A., Lejeune, F., Audinot, V., Rivet, J., Schreiber, R., Dekeyne, A., Spedding, M., et al. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37777-8 · Cited by 74
Reboxetine: additional benefits to the depressed patient.
Montgomery, S. A. (1997) · PubMed · Cited by 73
The 5-HT1B Receptor: Behavioral Implications
Clark, M. S., Neumaier, J. F., PhD, Neumaier, A. J. F., MD, & PhD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4247 · Cited by 73
Possible neurobiological mechanisms underlying faster onset of antidepressant action.
Blier, P. U. (2001) · PubMed · Cited by 72
Pérez, V., Puigdemont, D., Gilaberte, I., Álvarez, E., & Artigas, F. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200102000-00008 · Cited by 70
Effects of α-Methyl-Para-Tyrosine (AMPT) in Drug-Free Depressed Patients
Miller, H. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00072-l · Cited by 65
A multicentre, double‐blind, clomipramine‐controlled efficacy and safety study of org 3770
Richou, H., Ruimy, P., Charbaut, J., Delisle, J. P., Brunner, H., Patris, M., & Zivkov, M. (1995) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470100403 · Cited by 65
Clement, H., Gemsa, D., & Wesemann, W. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90509-3 · Cited by 64
Duncan, G. E., Paul, I. A., Harden, T. K., et al. (1985) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23459-0 · Cited by 62
Sacchetti, G., Bernini, M., Gobbi, M., Parini, S., Pirona, L., Mennini, T., & SAMANIN, R. (2001) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000334 · Cited by 59
Serotonin uptake inhibitors: Uses in clinical therapy and in laboratory research
Fuller, R. W. (1995) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7164-8_5 · Cited by 57
Noradrenaline in basic models of depression
Leonard, B. E. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(97)00415-x · Cited by 56
Piñeyro, G., & Blier, P. U. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12337-9 · Cited by 50
Bosker, F. J., Klompmakers, A. A., & Westenberg, H. G. M. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01141-2 · Cited by 50
Brain noradrenaline and the mechanisms of action of antidepressant drugs
Svensson, T. (2000) · Acta Psychiatrica Scandinavica Supplementum · doi:10.1034/j.1600-0447.2000.02604.x · Cited by 47
Autoreceptors and ?2-adrenoceptors at the serotonergic axons of rabbit brain cortex
Limberger, N., Bonanno, G., Sp�th, L., & Starke, K. (1986) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00500082 · Cited by 45
Cadogan, A., Marsden, C. A., Tulloch, I., & Kendall, D. A. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90108-f · Cited by 45
Antidepressant drugs: does it matter if they inhibit the reuptake of noradrenaline or serotonin?
Eriksson, E. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.00003.x · Cited by 43
Humble, M. B. (2000) · Acta Psychiatrica Scandinavica Supplementum · doi:10.1034/j.1600-0447.2000.02605.x · Cited by 42
Bupropion as Add-On Strategy in Difficult-to-Treat Bipolar Depressive Patients
Erfurth, A., Michael, N., Stadtland, C., & Arolt, V. (2002) · Neuropsychobiology · doi:10.1159/000049259 · Cited by 41
Tatarczynska, E., Kłodzińska, A., & Chojnacka-Wójcik, E. (2002) · PubMed · Cited by 40
The Effect of Mianserin on Alpha-2 Adrenergic Receptor Function in Depressed Patients
Charney, D. S., Heninger, G. R., & Sternberg, D. E. (1984) · The British Journal of Psychiatry · doi:10.1192/bjp.144.4.407 · Cited by 39
[The action of isonicotinyl-hydrazide used in the treatment of depressive states].
Delay, J., Laine, B., & Jf, B. (1952) · PubMed · Cited by 36
Rapid desensitization of 5-HT1A receptors in Fawn-Hooded rats after chronic fluoxetine treatment
Kántor, S., Gráf, M., Anheuer, Z. E., & Bagdy, G. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00126-7 · Cited by 35
Crews, F. T., Scott, J. A., & Shorstein, N. H. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90082-5 · Cited by 34
D’Aquila, P. S., Peana, A. T., Panin, F., Grixoni, C., Cossu, M. L., & Serra, G. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02731-0 · Cited by 34
Durlach-Misteli, C., & Van, J. M. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90505-x · Cited by 31
D’Aquila, P. S., Collu, M., Devoto, P., et al. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00189-8 · Cited by 23
Stastny, J., Konstantinidis, A., Schwarz, M., Rosenthal, N. E., Vitouch, O., Kasper, S. F., & Neumeister, A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01453-1 · Cited by 23
Imaging strategies in depression
Grasby, P. M. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300407 · Cited by 23
Ossowska, G., Nowak, G., Klenk-Majewska, B., Danilczuk, Z., & Zebrowska-Łupina, I. (2002) · PubMed · Cited by 21
Effect of repeated treatment with mirtazapine on the central alpha1-adrenergic receptors.
Rogoz, Z., Wróbel, A., Dlaboga, D., Maj, J., & Dziedzicka‐Wasylewska, M. (2002) · PubMed · Cited by 19
The need for new and better antidepressants: reboxetine a new option
Dencker, S. J. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.02602.x · Cited by 17
Some effects of mianserin on monoamine metabolism in the rat brain.
Leonard, B. E. (1978) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1978.tb04568.x · Cited by 16
Guo, T., Reid, K., Davies, F. M., Nacif-Coelho, C., Rabin, B. C., Gonzalez, F., & Maze, M. (1998) · Anesthesiology · doi:10.1097/00000542-199806000-00028 · Cited by 13
Effect of repeated treatment with reboxetine on the central alpha1-adrenergic system.
Rogóż, Z., & Kolasiewicz, W. (2002) · PubMed · Cited by 10
Cited by
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Pathophysiological mechanisms implicated in postpartum depression
Payne, J. L., & Maguire, J. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.12.001 · Cited by 459
Abd El‐Hack, M. E., El‐Saadony, M. T., Swelum, A. A., Arif, M., Abo Ghanima, M. M., Shukry, M., Noreldin, A., Taha, A. E., & El‐Tarabily, K. A. (2021) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.11372 · Cited by 392
Antidepressant activity of curcumin: involvement of serotonin and dopamine system
Kulkarni, S. K., Bhutani, M. K., & Bishnoi, M. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1300-y · Cited by 337
Harshaw, C. (2015) · Psychological Bulletin · doi:10.1037/a0038101 · Cited by 302
“Serotoninergic theories of depression and antidepressant drug action nonetheless focused almost exclusively on disruptions in serotonin functioning in the brain (e.g., Elhwuegi, 2004; Ressler & Nemeroff, 2000; see Hale, Raison, & Lowry, 2013, for an exception).”
Background
Metadata
- Authors
- Elhwuegi, A. S.
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2004-05
- Volume
- 28
- Issue
- 3
- Pages
- 435-451
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W2092843998
- Cited by
- 504
- References
- 130
- FWCI
- 10.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.